Navigation

🏠 Home 📰 Latest News 🌍 World 🇮🇳 India 💼 Business 💻 Technology ⚽ Sports 🎬 Entertainment 🏥 Health
Biggest News Aggregation in the World
📰 Cell Surface News

Page 4 - Cell Surface News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Cell Surface. Real-time updates on events, politics, business and more.

Genmab and AbbVie Announce Topline Results for Epcoritamab (DuoBody®-CD3xCD20) From Phase 1/2 Trial in Patients with Relapsed/Refractory Large B-cell Lymphoma (LBCL) - Press Release

April 14, 2022
Company Announcement Based on the topline results from the EPCORE™ NHL-1 clinical trial, Genmab and AbbVie will engage global regulatory authorities t
New Jersey United States Mohamed Zaki Global Oncology Development Macrophage Properties Journal Of Immunology Baltimore Exchange Commission
Source: wiredprnews.com

Genmab A/S: Genmab and AbbVie Announce Topline Results for Epcoritamab (DuoBody-CD3xCD20) From Phase 1/2 Trial in Patients with Relapsed/Refractory Large B-cell Lymphoma (LBCL)

April 13, 2022
Company Announcement Based on the topline results from the EPCORE NHL-1 clinical trial, Genmab and AbbVie will engage global regulatory authorities to discuss next steps Data from the clinical
New Jersey United States Liz Shea Ilke Limoncu Mabel Martinez Marisol Peron
Source: finanznachrichten.de

AbbVie and Genmab Announce Topline Results for Epcoritamab (DuoBody®-CD3xCD20) from Phase 1/2 Trial in Patients with Relapsed/Refractory Large B-cell Lymphoma (LBCL)

April 13, 2022
/PRNewswire/ -- AbbVie (NYSE: ABBV) and Genmab A/S (Nasdaq: GMAB) today announced topline results from the first cohort of the EPCORE™ NHL-1 phase 1/2 clinical...
New Jersey United States Mohamed Zaki Macrophage Propertiesj Immunol Exchange Commission Hodgkin Lymphoma Research Foundation
Source: prnewswire.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

AbbVie to Highlight New Advances in Blood Cancer Research and Expanding Oncology Pipeline at 63rd ASH Annual Meeting

November 4, 2021
ABBVie will present results from nearly 30 abstracts across eight types of cancer during the upcoming American Society of Hematology Annual Meeting in Atlanta, Georgia . "We are dedicated to transforming standards of care for people living with blood cancers," said Mohamed Zaki M.D., Ph.D, vice president and global head of oncology development, AbbVie. "The data we are presenting at the ASH Annual Meeting build on ...
United States Mohamed Zaki Obinutuzumab Clb Venetoclax Rituximab Ven Janssen Biotech Inc Abbvie Company
Source: investingnews.com

Genmab A/S: Genmab Announces Multiple Abstracts to be Presented at the 63rd Annual Meeting and Exposition of the American Society of Hematology (ASH)

November 4, 2021
Poster presentations highlighting safety and preliminary efficacy data of epcoritamab (DuoBody-CD3xCD20) in combination with other treatments in patients with B-cell non-Hodgkin lymphoma (NHL)
United States New Jersey Marisol Peron Genmab Duobody Andrew Carlsen Exposition Of The American Society Hematology
Source: finanznachrichten.de

MSNBC The 11th Hour With Brian Williams August 31, 2021 06:04:00

August 31, 2021
To play out for the next few days, we were told to prepare for a few days. the city was not under evacuation order as you know, the mayor has now said, if you did evacuate, dont come back here. because its not going to be worth coming back to a hot, and entirely dark city. were letting ourselves with car vehicles and car battery operated. late you saw one of the moon out a month ago its put me in the dark, its quite something to be in a completely populated big, city in which there are no lights...
Americans Don T New Orleans City In In The Dark Car Battery Car Vehicles
Source: archive.org

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science